Epinephrine 0.3 MG auto-inject 2S
Ended Awarded Last action
- Contract number
- SPE2DR26FXUK5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,207
Award facts
- Contract value 100% obligated
- $10,207.09 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,207.09 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-inject units on January 16, 2026, with a completion date of January 20, 2026. This firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (vehicle SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the supply of a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, medical devices, and specialized equipment such as auto-injectors to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The DLA's Pharmaceutical Prime Vendor Global Program Generation V is anticipated to make multiple awards across separate regions, demonstrating the strategic importance of maintaining diverse pharmaceutical suppliers for federal medical operations.
Quick answers
Who was awarded contract SPE2DR26FXUK5?
SPE2DR26FXUK5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26FXUK5 worth?
The government has obligated $10,207 on SPE2DR26FXUK5.
Is contract SPE2DR26FXUK5 an order under another contract?
Yes. SPE2DR26FXUK5 is a delivery order under SPE2DR25D3004, an indefinite delivery contract.
Was contract SPE2DR26FXUK5 competed?
The extent of competition for SPE2DR26FXUK5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award